
Evommune, Inc. — Investor Relations & Filings
Evommune, Inc. is a clinical-stage biotechnology company dedicated to discovering and developing innovative therapies for immune-mediated chronic inflammatory diseases. The company employs leading-edge science and tissue-based insights to target the root causes and key drivers of inflammation. Evommune is advancing a pipeline of differentiated product candidates, aiming to improve patients' daily lives and prevent the long-term effects of uncontrolled inflammation.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 424B3 | 2026-05-07 | English | |
| 10-Q | 2026-05-07 | English | |
| 8-K | 2026-05-07 | English | |
| Regulatory Filings 2026 | 2026-04-27 | English | |
| 424B3 | 2026-04-24 | English | |
| ARS | 2026-04-21 | English |
Browse filings by year
2 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46723775 | 424B3 | 2026-05-07 | English | ||
| 46723774 | 10-Q | 2026-05-07 | English | ||
| 46723771 | 8-K | 2026-05-07 | English | ||
| 46723776 | Regulatory Filings 2026 | 2026-04-27 | English | ||
| 46723777 | 424B3 | 2026-04-24 | English | ||
| 46723781 | ARS | 2026-04-21 | English | ||
| 46723779 | DEFA14A | 2026-04-21 | English | ||
| 46723783 | DEF 14A | 2026-04-21 | English | ||
| 46723784 | S-1 | 2026-04-17 | English | ||
| 46723789 | 8-K | 2026-04-13 | English | ||
| 46723790 | S-8 | 2026-03-05 | English | ||
| 46723802 | 10-K | 2026-03-05 | English | ||
| 46723808 | 8-K | 2026-03-05 | English | ||
| 46723809 | Major Shareholding Notification 2026 | 2026-02-19 | English | ||
| 46723810 | Major Shareholding Notification 2026 | 2026-02-18 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Delta-Fly Pharma, Inc.
Biopharmaceutical firm developing novel anticancer drugs fr…
|
4598 | JP | Professional, scientific and te… |
|
DELTA GOLD TECHNOLOGIES LIMITED
Develops and licenses IP for the quantum computing sector u…
|
DGQ | GB | Professional, scientific and te… |
|
DG INNOVATE PLC
Develops sustainable technologies for electric mobility and…
|
DGI | GB | Professional, scientific and te… |
|
Dianthus Therapeutics, Inc. /DE/
Clinical-stage biotech developing therapies for severe auto…
|
DNTH | US | Professional, scientific and te… |
|
DIMERIX LIMITED
Develops GPCR-targeted therapies for inflammatory kidney an…
|
DXB | AU | Professional, scientific and te… |
|
Dogwood Therapeutics, Inc.
A biotech company developing novel therapeutics for pain an…
|
DWTX | US | Professional, scientific and te… |
|
DORSAVI LTD
Develops clinical-grade wearable sensors and software for h…
|
DVL | AU | Professional, scientific and te… |
|
DreamCIS INC.
Contract research organization for pharma, biotech, and med…
|
223250 | KR | Professional, scientific and te… |
|
DT&CRO CO., Ltd.
A full-service CRO providing non-clinical and clinical stud…
|
383930 | KR | Professional, scientific and te… |
|
Dundee Sustainable Technologies Inc.
Develops proprietary, sustainable metallurgical processes f…
|
DST | CA | Professional, scientific and te… |
Evommune, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/72596/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=72596 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=72596 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=72596 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 72596}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Evommune, Inc. (id: 72596)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.